
Conference Coverage
Latest Content

Bridging the Divide: Unveiling an Opportunity for Biosimilar Development

Careology Shows How Remote Monitoring Works in 4 Very Different “Rooms”

Reimagine Care Pitches a “Travel Desk” for Patients Between Cancer Visits

Anemia, Iron Deficiency Tied to Acute Heart Failure in Pregnancy

Beyond Traditional Metrics: Rethinking Access and the Unseen Impact of eConsults

Shorts










Center on Health Equity & Access
All News

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Among 821,327 outpatients, cystatin C–based eGFR at least 30% below creatinine-based eGFR was linked to higher death and heart failure rates.

Faculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the gap.

The FDA approved cemdisiran (Livsayis; Regeneron), a subcutaneous siRNA dosed every 3 months, for AChR-positive generalized myasthenia gravis.

In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.

Pharmacy teams can shorten the time of Medicare GLP-1 Bridge approvals, but 2027 approval windows may leave patients without titration check-ins.

An employer coalition's new guide outlines how workplaces can prevent and manage diabetes, from benefit design to accommodations.

CRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.

Obinutuzumab (Gazyva) led to complete remission of proteinuria in more patients than tacrolimus did, according to the FDA.

Infectious disease and urology clinicians described unclear treatment goals, infusion limits, and access barriers for newer UTI agents.



























